Spin-off news
Here you can find news from MPG spin-off companies.
Alnylam
Alnylam Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration (FDA) for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
Dewpoint Therapeutics
Dewpoint Therapeutics Granted Second Breakthrough Condensates Platform Technology Patent by US Patent Office
Cardior
Cardior Announces First Patient Dosed in Phase 2 Study Evaluating Efficacy and Safety of Non-coding RNABased Lead Candidate CDR132L in Heart Failure Patients PostMyocardial Infarction
Evotec
Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance